Predictive Glucose Trends From Continuous Glucose Monitoring: Friend or Foe in Clinical Decision Making?
Kathryn L FantasiaKatherine L ModzelewskiDevin SteenkampPublished in: Journal of diabetes science and technology (2019)
In this commentary, we briefly review the currently recommended approaches to interpretation and management of continuous glucose monitor (CGM) rate of change (ROC) trend arrows and discuss the inherent difficulty in incorporating practical recommendations for their application into routine clinical care. We have limited our review and discussion to the currently available Dexcom G5 and G6 CGM systems and Abbott's Freestyle Libre flash glucose monitor (FGM) system, as they are the most widely used and currently approved for nonadjunctive use in the United States.